NYSE: STE
- Last Close 205.47
- Sector Healthcare
- Industry Medical Devices
- Investment Style Mid Blend
- Day Range 202.58 – 206.51
- Year Range 159.21 – 229.98
- Market Cap 20.2697 Bil
- Volume / Avg 481,962.0 / 466,653.1
- Price / Sales 4.15
- Price / Book 3.34
- Forward Div Yield 0.91%
- Trailing Div Yield 1.12%
Morningstar‘s Stock Analysis STE
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Capital Allocation
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile STE
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
Related Articles STE
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of STE’s competitive advantage.
Steris PLC
XNYS: STE
| Ecolab Inc
XNYS: ECL
| Stryker Corp
XNYS: SYK
| Getinge AB Class B
XSTO: GETI B
| |
Price
| 205.47 | 173.10 | 278.30 | 254.00 |
Currency
| USD | USD | USD | SEK |
Change
| +$3.05 (1.51%) | +$3.98 (2.35%) | −$0.27 (0.10%) | +$2.70 (1.07%) |
Market Cap
| 20.27 Bil | 49.29 Bil | 105.64 Bil | 69.18 Bil |
Industry
| Medical Devices | Specialty Chemicals | Medical Devices | Medical Devices |
Sector
|
Healthcare
|
Basic Materials
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Steris PLC Stock
Yes. STE has a forward dividend yield of 0.92%.
See
STE’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
STE’s market cap is 20.27 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
STE’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
STE’s price/sales is 4.09.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
STE’s price/forward earnings is 189.18.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
STE’s price/book is 3.29.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See STE’s valuation ratios compared to the Market Index.
STE’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare STE’s historical performance against its industry peers and the overall market.